Your browser doesn't support javascript.
loading
Extending the ambit of SGLT2 inhibitors beyond diabetes: a review of clinical and preclinical studies on non-diabetic kidney disease.
Nayak, Saurabh; Rathore, Vinay; Bharati, Joyita; Sahu, Kamal Kant.
Affiliation
  • Nayak S; Department of Nephrology, All India Institute of Medical Science, Raipur, India.
  • Rathore V; Department of Nephrology, All India Institute of Medical Science, Raipur, India.
  • Bharati J; Department of Nephrology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
  • Sahu KK; Division of Hematology and Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah Salt Lake City, Salt Lake City, Utah, USA.
Expert Rev Clin Pharmacol ; 14(12): 1513-1526, 2021 Dec.
Article in En | MEDLINE | ID: mdl-35020563
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic / Sodium-Glucose Transporter 2 Inhibitors Limits: Humans Language: En Journal: Expert Rev Clin Pharmacol Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic / Sodium-Glucose Transporter 2 Inhibitors Limits: Humans Language: En Journal: Expert Rev Clin Pharmacol Year: 2021 Document type: Article Affiliation country: Country of publication: